全是干货!27种STEMI治疗药物使用要点大集合!

2021-08-03 MedSci整理 MedSci原创

吐血整理!《ST段抬高型心肌梗死基层合理用药威廉亚洲博彩公司 》2021

ST段抬高型心肌梗死(ST-segment elevated myocardial infarction, STEMI)是冠心病的严重类型,其指急性心肌缺血性坏死,通常多为在冠状动脉不稳定斑块破裂、糜烂、侵蚀及内皮损伤基础上继发血栓形成而致冠状动脉急性、持续、完全闭塞,血供急剧减少或中断,而使心肌细胞缺血、损伤及坏死的临床综合征。

STEMI的治疗原则是尽快恢复心肌的血液灌注,挽救濒死的心肌、防止梗死面积扩大,保护心功能,及时处理严重心律失常、泵衰竭和各种并发症,防止猝死,使患者不但能度过急性期,且康复后还能保持尽可能多的有功能的心肌。

一、药物治疗原则

STEMI药物治疗针对其临床表现和发病机制,主要包括镇痛治疗、溶栓治疗、抗凝治疗、抗血小板治疗、抗缺血治疗及调脂治疗、肾素‑血管紧张素‑醛固酮系统抑制剂等改善预后的治疗。

 

图片

二、治疗药物详解

1、哌替啶

图片

 

2、吗啡

图片

 

3、尿激酶

图片

 

4、阿替普酶

图片

 

5、瑞替普酶 

 

图片

 

6、阿司匹林

 

图片

 

7、氯吡格雷

 

图片

 

8、替格瑞洛

 

图片

 

9、肝素

 

图片

 

10、低分子量肝素

 

图片

 

11、硝酸甘油

 

图片

 

12、硝酸异山梨酯

 

图片

 

13、单硝酸异山梨酯

 

图片

 

14、尼可地尔

 

图片

 

15、阿替洛尔

 

图片

 

16、美托洛尔

 

图片

 

17、比索洛尔

 

图片

 

18、卡托普利

 

图片

 

19、依那普利

图片

 

20、赖诺普利

 

图片

 

21、缬沙坦

 

图片

 

22、螺内酯

 

图片

 

23、辛伐他汀

 

图片

 

24、阿托伐他汀

 

图片

 

25、瑞舒伐他汀

图片

 

26、非诺贝特

 

图片

 

27、依折麦布

 

图片

 

参考文献:
ST段抬高型心肌梗死基层合理用药威廉亚洲博彩公司 .[J]中华全科医师杂志,  2021,20(4) : 397-409. 
DOI: 10.3760/cma.j.cn114798-20210209-00151

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1971600, encodeId=a8b719e160015, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Thu Apr 07 06:47:05 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921841, encodeId=9347192184126, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Fri Jul 15 23:47:05 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482330, encodeId=fbe61482330bb, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Aug 05 04:47:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004928, encodeId=013d100492803, content=非常好的总结资料,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70cd5449162, createdName=ms3000001148858725, createdTime=Tue Aug 03 18:06:43 CST 2021, time=2021-08-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1971600, encodeId=a8b719e160015, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Thu Apr 07 06:47:05 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921841, encodeId=9347192184126, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Fri Jul 15 23:47:05 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482330, encodeId=fbe61482330bb, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Aug 05 04:47:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004928, encodeId=013d100492803, content=非常好的总结资料,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70cd5449162, createdName=ms3000001148858725, createdTime=Tue Aug 03 18:06:43 CST 2021, time=2021-08-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1971600, encodeId=a8b719e160015, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Thu Apr 07 06:47:05 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921841, encodeId=9347192184126, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Fri Jul 15 23:47:05 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482330, encodeId=fbe61482330bb, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Aug 05 04:47:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004928, encodeId=013d100492803, content=非常好的总结资料,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70cd5449162, createdName=ms3000001148858725, createdTime=Tue Aug 03 18:06:43 CST 2021, time=2021-08-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1971600, encodeId=a8b719e160015, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Thu Apr 07 06:47:05 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921841, encodeId=9347192184126, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Fri Jul 15 23:47:05 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482330, encodeId=fbe61482330bb, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Aug 05 04:47:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004928, encodeId=013d100492803, content=非常好的总结资料,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70cd5449162, createdName=ms3000001148858725, createdTime=Tue Aug 03 18:06:43 CST 2021, time=2021-08-03, status=1, ipAttribution=)]
    2021-08-03 ms3000001148858725

    非常好的总结资料,学习了

    0

相关威廉亚洲官网

今晚19:00直播:石家庄市第一医院胡喜田主任:急性心肌梗死心电图诊断

【4月29日晚19:00直播】课程内容:直播分享+问答互动+《心内科速查手册》纸质书抽送

NEJM:FFR和血管造影指导下的多支血管PCI治疗心肌梗死比较(FLOWER-MI研究)

2021年,中国冠脉介入治疗“大踏步”步入生理功能学评估的大时代,不管是传统的FFR(包括FFR压力微导管),还是算法衍生出来的QFR、caFFR等,都在临床上积极地开展着推广

J INTERN MED:ST段抬高型心肌梗死患者入院时精氨酸酶1水平表达上调

入院时精氨酸酶1的基因和蛋白表达显著增加表明精氨酸酶1在STEMI发生发展中发挥着重要作用。

JACC:心肌梗死后ST段抬高出现越晚,患者的长期预后越差!

心肌梗死后ST段抬高出现越晚,患者的长期预后越差

JACC:新冠肺炎大流行对ST段抬高型心肌梗死诊疗和预后的影响

近日,印度疫情失控、医疗系统奔溃、氧气缺乏、当街焚尸等宛若“人间炼狱”般的现实提醒着williamhill asia ,新冠疫情仍尚未结束。

JACC:经导管主动脉瓣置换术后发生ST段抬高型心肌梗死的患者的临床特征及预后

经导管主动脉瓣置换术(TAVR)后发生急性冠脉综合征的患者发生ST段抬高型心肌梗死(STEMI)的风险最高

拓展阅读

ST段抬高型心肌梗死基层诊疗威廉亚洲博彩公司 (实践版·2019)

中华医学会(CMA,Chinese Medical Association) · 2020-12-20

ST段抬高型心肌梗死基层诊疗威廉亚洲博彩公司 (2019年)

中华医学会(CMA,Chinese Medical Association) · 2020-12-20

2019 CCS/CAIC威廉亚洲博彩公司 :ST段抬高型心肌梗死的紧急管理

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2019-02-10

2015 ACC/AHA/SCAI威廉亚洲博彩公司 :直接经皮冠状动脉介入治疗ST段抬高型心肌梗死

美国心脏病学会(ACC,American College of Cardiology) · 2015-10-20